ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Maintenance Pembrolizumab Did Not Improve PFS in Small-Cell Lung Cancer

Maintenance Pembrolizumab Did Not Improve PFS in Small-Cell Lung Cancer

 

In this video, Shirish M. Gadgeel, MD, of the University of Michigan, discusses a phase II trial that studied pembrolizumab in the maintenance setting for the treatment of extensive-stage small-cell lung cancer patients.

Gadgeel presented results of the study (abstract 8504) at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2–6 in Chicago.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.